vs

Side-by-side financial comparison of Bitcoin Depot Inc. (BTM) and 4D Molecular Therapeutics, Inc. (FDMT). Click either name above to swap in a different company.

Bitcoin Depot Inc. is the larger business by last-quarter revenue ($162.5M vs $85.1M, roughly 1.9× 4D Molecular Therapeutics, Inc.). 4D Molecular Therapeutics, Inc. runs the higher net margin — 22.8% vs 3.4%, a 19.4% gap on every dollar of revenue. On growth, 4D Molecular Therapeutics, Inc. posted the faster year-over-year revenue change (8508900.0% vs 20.1%). 4D Molecular Therapeutics, Inc. produced more free cash flow last quarter ($28.5M vs $2.5M). Over the past eight quarters, 4D Molecular Therapeutics, Inc.'s revenue compounded faster (5412.6% CAGR vs -4.9%).

Bitcoin Depot Inc. is one of the largest cryptocurrency ATM operators across North America. It provides retail consumers with accessible in-person kiosks to buy and sell Bitcoin and other leading digital assets, alongside online crypto purchase services via bank transfer. Its self-service kiosks are located in high-traffic retail spaces including grocery stores, gas stations and convenience stores.

4D Molecular Therapeutics is a clinical-stage biotechnology company specializing in the research and development of targeted adeno-associated virus (AAV) gene therapies. Its core product candidates address unmet medical needs in ophthalmology, cardiology, and pulmonary disease segments, serving global patient populations with rare and common hard-to-treat conditions.

BTM vs FDMT — Head-to-Head

Bigger by revenue
BTM
BTM
1.9× larger
BTM
$162.5M
$85.1M
FDMT
Growing faster (revenue YoY)
FDMT
FDMT
+8508879.9% gap
FDMT
8508900.0%
20.1%
BTM
Higher net margin
FDMT
FDMT
19.4% more per $
FDMT
22.8%
3.4%
BTM
More free cash flow
FDMT
FDMT
$25.9M more FCF
FDMT
$28.5M
$2.5M
BTM
Faster 2-yr revenue CAGR
FDMT
FDMT
Annualised
FDMT
5412.6%
-4.9%
BTM

Income Statement — Q3 FY2025 vs Q4 FY2025

Metric
BTM
BTM
FDMT
FDMT
Revenue
$162.5M
$85.1M
Net Profit
$5.5M
$19.4M
Gross Margin
Operating Margin
7.3%
17.3%
Net Margin
3.4%
22.8%
Revenue YoY
20.1%
8508900.0%
Net Profit YoY
690.4%
139.1%
EPS (diluted)
$0.08
$0.43

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BTM
BTM
FDMT
FDMT
Q4 25
$85.1M
Q3 25
$162.5M
$90.0K
Q2 25
$172.1M
$15.0K
Q1 25
$164.2M
$14.0K
Q4 24
$1.0K
Q3 24
$135.3M
$3.0K
Q2 24
$163.1M
$5.0K
Q1 24
$138.5M
$28.0K
Net Profit
BTM
BTM
FDMT
FDMT
Q4 25
$19.4M
Q3 25
$5.5M
$-56.9M
Q2 25
$6.1M
$-54.7M
Q1 25
$4.2M
$-48.0M
Q4 24
Q3 24
$-939.0K
$-43.8M
Q2 24
$-2.6M
$-35.0M
Q1 24
$-1.5M
$-32.4M
Operating Margin
BTM
BTM
FDMT
FDMT
Q4 25
17.3%
Q3 25
7.3%
-67983.3%
Q2 25
9.2%
-396373.3%
Q1 25
10.8%
-383007.1%
Q4 24
Q3 24
4.1%
-1704400.0%
Q2 24
4.7%
-849120.0%
Q1 24
0.5%
-136200.0%
Net Margin
BTM
BTM
FDMT
FDMT
Q4 25
22.8%
Q3 25
3.4%
-63195.6%
Q2 25
3.5%
-364386.7%
Q1 25
2.6%
-342657.1%
Q4 24
Q3 24
-0.7%
-1461433.3%
Q2 24
-1.6%
-699060.0%
Q1 24
-1.1%
-115717.9%
EPS (diluted)
BTM
BTM
FDMT
FDMT
Q4 25
$0.43
Q3 25
$0.08
$-1.01
Q2 25
$0.16
$-0.98
Q1 25
$0.20
$-0.86
Q4 24
Q3 24
$-0.05
$-0.79
Q2 24
$-0.13
$-0.63
Q1 24
$-0.25
$-0.66

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BTM
BTM
FDMT
FDMT
Cash + ST InvestmentsLiquidity on hand
$59.3M
$402.7M
Total DebtLower is stronger
$67.5M
Stockholders' EquityBook value
$21.0M
$505.7M
Total Assets
$125.3M
$566.7M
Debt / EquityLower = less leverage
3.21×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BTM
BTM
FDMT
FDMT
Q4 25
$402.7M
Q3 25
$59.3M
$305.1M
Q2 25
$48.0M
$293.2M
Q1 25
$35.0M
$321.4M
Q4 24
$424.9M
Q3 24
$32.2M
$501.9M
Q2 24
$43.9M
$541.9M
Q1 24
$42.2M
$525.9M
Total Debt
BTM
BTM
FDMT
FDMT
Q4 25
Q3 25
$67.5M
Q2 25
$66.5M
Q1 25
$56.2M
Q4 24
Q3 24
$44.5M
Q2 24
$41.2M
Q1 24
$37.6M
Stockholders' Equity
BTM
BTM
FDMT
FDMT
Q4 25
$505.7M
Q3 25
$21.0M
$369.0M
Q2 25
$4.7M
$420.9M
Q1 25
$-4.6M
$469.7M
Q4 24
$510.6M
Q3 24
$-7.9M
$552.9M
Q2 24
$4.4M
$588.3M
Q1 24
$5.0M
$600.6M
Total Assets
BTM
BTM
FDMT
FDMT
Q4 25
$566.7M
Q3 25
$125.3M
$424.0M
Q2 25
$109.1M
$473.6M
Q1 25
$89.7M
$515.7M
Q4 24
$560.4M
Q3 24
$87.4M
$604.0M
Q2 24
$97.5M
$620.1M
Q1 24
$90.1M
$629.9M
Debt / Equity
BTM
BTM
FDMT
FDMT
Q4 25
Q3 25
3.21×
Q2 25
14.18×
Q1 25
Q4 24
Q3 24
Q2 24
9.27×
Q1 24
7.54×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BTM
BTM
FDMT
FDMT
Operating Cash FlowLast quarter
$6.6M
$28.6M
Free Cash FlowOCF − Capex
$2.5M
$28.5M
FCF MarginFCF / Revenue
1.6%
33.5%
Capex IntensityCapex / Revenue
2.5%
0.1%
Cash ConversionOCF / Net Profit
1.20×
1.47×
TTM Free Cash FlowTrailing 4 quarters
$27.1M
$-109.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BTM
BTM
FDMT
FDMT
Q4 25
$28.6M
Q3 25
$6.6M
$-46.5M
Q2 25
$10.2M
$-43.4M
Q1 25
$16.3M
$-47.8M
Q4 24
$-134.6M
Q3 24
$5.8M
$-29.4M
Q2 24
$10.1M
$-30.2M
Q1 24
$1.3M
$-29.1M
Free Cash Flow
BTM
BTM
FDMT
FDMT
Q4 25
$28.5M
Q3 25
$2.5M
$-46.6M
Q2 25
$9.8M
$-43.4M
Q1 25
$15.9M
$-48.4M
Q4 24
$-138.4M
Q3 24
$-1.0M
$-31.2M
Q2 24
$7.6M
$-30.6M
Q1 24
$789.0K
$-29.8M
FCF Margin
BTM
BTM
FDMT
FDMT
Q4 25
33.5%
Q3 25
1.6%
-51765.6%
Q2 25
5.7%
-289620.0%
Q1 25
9.7%
-345635.7%
Q4 24
-13837100.0%
Q3 24
-0.8%
-1038966.7%
Q2 24
4.7%
-611840.0%
Q1 24
0.6%
-106421.4%
Capex Intensity
BTM
BTM
FDMT
FDMT
Q4 25
0.1%
Q3 25
2.5%
101.1%
Q2 25
0.2%
440.0%
Q1 25
0.2%
4507.1%
Q4 24
378600.0%
Q3 24
5.0%
59266.7%
Q2 24
1.5%
6980.0%
Q1 24
0.4%
2535.7%
Cash Conversion
BTM
BTM
FDMT
FDMT
Q4 25
1.47×
Q3 25
1.20×
Q2 25
1.67×
Q1 25
3.88×
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons